TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach

Acquired resistance to oxaliplatin is considered as the primary reason for failure in colorectal cancer (CRC) therapy. Identifying the underlying resistance mechanisms may improve CRC treatment. The present study aims to identify the key genes involved in acquired oxaliplatin-resistant in CRC by con...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheraghi-shavi, Tayebeh, Jalal, Razieh, Minuchehr, Zarrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399784/
https://www.ncbi.nlm.nih.gov/pubmed/37535601
http://dx.doi.org/10.1371/journal.pone.0289535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399784/
https://www.ncbi.nlm.nih.gov/pubmed/37535601
http://dx.doi.org/10.1371/journal.pone.0289535

Ejemplares similares